Seeking Alpha

Intuitive Surgical (ISRG +3.1%) trades higher ahead of tomorrow's Q3 report and an upgrade to...

Intuitive Surgical (ISRG +3.1%) trades higher ahead of tomorrow's Q3 report and an upgrade to Outperform by JPMorgan earlier today. The firm says that despite declines in domestic prostate-cancer surgeries there's compelling risk/reward in the shares, with meaningful opportunities emerging in other cancers and additional areas which, collectively, should more than offset the prostate-cancer softness and drive up Street estimates for the next several years.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector